65,437 trials
Asthma
Primary: Peak Forced Expiratory Volume in 1 Second (FEV1) Response Within 3 Hours Post Dosing (0-3h) After a Treatment Period of 24 Weeks. — 0.248; 0.401 Liter — p=<0.0001
Prostate Cancer
Primary: Change From Baseline in Prostate Size Based on Trans Rectal Ultra Sound (TRUS) at Week 12 (Full Analysis Set) — -36.0; -35.3 milliliter — p=0.8942
Breast Cancer · Male Breast Cancer · Recurrent Breast Cancer
Primary: Response Rate — 0 percentage of participants
Breast Cancer
Primary: Number of Patients With Pathological Complete Response (pCR) in the Breast and Nodes for Patients With HER2-positive LABC Following Neoadjuvant Treatment (Cohort A) — 34…
Glioblastoma Multiforme
Primary: Tumor-specific Cytotoxic T-cell Response — 0.496; 0.4836 10^9 cells/L
Seasonal Allergic Rhinitis
Primary: Change From Baseline in 12-hour Reflective Total Nasal Symptom Score (rTNSS) — -5.6; -4.7; -4.2; -2.9 units on a scale
Sleep Disorders · Hypertension
Primary: Sleep Quality — 88.1; 80.5 % (% asleep during 8 hour opportunity)
Sepsis
Primary: Volume of Distribution (Vd) — 28.52 liters
Acne Vulgaris · Post Inflammatory Hyperpigmentation
Primary: Percentage of Participants With Improvement in Acne IGA (Investigator Global Assessment) — 92 percentage of participants
Pain · Anxiety
Primary: Pain From Venipuncture — 2.2; 2.1 scores on a scale — p=0.71
Children Born With Serious Intra-uterine Growth Retardation
Primary: Final Height — 145.90; 150.06; 153.27; 155.59 cm
Non-transfusion Dependent Thalassemia
Primary: Core Study: Change in Liver Iron Concentration (LIC) From Baseline to Week 52 — -1.95; -3.80; 0.38 mg iron (Fe)/g dry weight (dw)
Thromboembolism
Primary: The Percent of Out of Range (OOR) International Normalized Prothrombin Time Ratio (INRs) in the Standard and Modified Pharmacogenetic Arms. — 30.6; 31.8 percent — p=<0.05
Adult T-cell Leukemia-lymphoma
Primary: Overall Response Rate (ORR) — 50 percentage of participants with response
Glabellar Frown Lines
Primary: Percentage of Participants With Improvement in Subject Global Assessment of Change at Day 30 — 94.7; 0.00 Percentage of participants